GENSIGHT BIOLOGICS SA (SIGHT.PA) Stock Income Statement
Europe - Euronext Paris - EPA:SIGHT - FR0013183985 - Common Stock
0.101 EUR
0 (-0.59%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 194.00K | 1.50M | 1.27M | 2.58M | 5.28M | |||
| Operating Expenses | 15.39M | 17.31M | 30.96M | 30.42M | 33.40M | |||
| Research and Development | 9.97M | 11.40M | 16.60M | 18.94M | 22.55M | |||
| Selling, General, and Administrative Expenses | 5.61M | 5.86M | 13.02M | 12.73M | 12.78M | |||
| Operating Income | -15.20M | -15.81M | -29.70M | -27.84M | -28.13M | |||
| Interest Income/Expense | 122.00K | 1.83M | 3.48M | 538.00K | -489.00K | |||
| Other Income/Expense | -35.00K | -1.00K | -1.00K | -323.00K | 0.00 | |||
| Income Before Taxes | -15.11M | -13.98M | -26.22M | -27.62M | -28.61M | |||
| Income Tax | 7.00K | 21.00K | 0.00 | 5.00K | 2.00K | |||
| Net Income | -15.12M | -14.00M | -26.22M | -27.63M | -28.62M | |||
| EBITDA | -14.54M | -14.75M | -27.52M | -26.77M | -27.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.13 | -0.15 | -0.54 | -0.60 | -0.63 | |||
| Statistics | ||||||||
| Profit Margin | -7793.81% | -933.40% | -2069.46% | -1069.91% | -542.40% | |||
| Operating Profit Margin | -7835.05% | -1054.20% | -2343.80% | -1078.04% | -533.09% | |||
All data in EUR